Open access
Sep 2026
Dendritic-cell-targeting adeno-associated virus as potent cancer vaccine carriers
This study establishes this engineered AAV as a versatile and potent vaccine platform that effectively targets DCs, offering a promising approach for inducing robust and adaptable anti-tumor immunity.
Xin Wei, Xiang Li, Li-Xia Qi et al.
· Frontiers in Immunology · 0 citations